Titan Medical Inc. (TMD.TO)
CAD 1.13
(2150.0%)
CAD 1.13
(2150.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.68 Million USD | -79.61% |
| 2022 | 42.59 Million USD | -16.61% |
| 2021 | 51.08 Million USD | 223.22% |
| 2020 | 15.8 Million USD | -73.33% |
| 2019 | 59.26 Million USD | 49.32% |
| 2018 | 39.69 Million USD | 110.18% |
| 2017 | 18.88 Million USD | -31.4% |
| 2016 | 27.52 Million USD | -34.1% |
| 2015 | 41.77 Million USD | 194.13% |
| 2014 | 14.2 Million USD | 60.75% |
| 2013 | 8.83 Million USD | 12.04% |
| 2012 | 7.88 Million USD | -50.38% |
| 2011 | 15.88 Million USD | 326.89% |
| 2010 | 3.72 Million USD | 401.74% |
| 2009 | 741.82 Thousand USD | -65.55% |
| 2008 | 2.15 Million USD | 610.51% |
| 2007 | 303.09 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.1 Million USD | 31.43% |
| 2024 Q1 | 840 Thousand USD | 1172.73% |
| 2023 FY | 8.68 Million USD | -79.61% |
| 2023 Q2 | 4.64 Million USD | 69.29% |
| 2023 Q4 | 66 Thousand USD | -94.61% |
| 2023 Q1 | 2.74 Million USD | -70.74% |
| 2023 Q3 | 1.22 Million USD | -73.64% |
| 2022 Q1 | 12.11 Million USD | -7.39% |
| 2022 Q3 | 10.62 Million USD | -16.05% |
| 2022 Q4 | 9.38 Million USD | -11.66% |
| 2022 FY | 42.59 Million USD | -16.61% |
| 2022 Q2 | 12.65 Million USD | 4.4% |
| 2021 Q4 | 13.08 Million USD | -7.39% |
| 2021 FY | 51.08 Million USD | 223.22% |
| 2021 Q3 | 14.12 Million USD | 17.13% |
| 2021 Q1 | 11.8 Million USD | 46.3% |
| 2021 Q2 | 12.06 Million USD | 2.2% |
| 2020 Q2 | 2.26 Million USD | 42.56% |
| 2020 FY | 15.8 Million USD | -73.33% |
| 2020 Q1 | 1.59 Million USD | -55.95% |
| 2020 Q4 | 8.06 Million USD | 108.11% |
| 2020 Q3 | 3.87 Million USD | 70.9% |
| 2019 Q2 | 21 Million USD | 30.39% |
| 2019 Q3 | 18.53 Million USD | -11.74% |
| 2019 Q4 | 3.61 Million USD | -80.52% |
| 2019 FY | 59.26 Million USD | 49.32% |
| 2019 Q1 | 16.1 Million USD | 2.05% |
| 2018 FY | 39.69 Million USD | 110.18% |
| 2018 Q4 | 15.78 Million USD | 45.47% |
| 2018 Q3 | 10.85 Million USD | 34.64% |
| 2018 Q2 | 8.05 Million USD | 61.35% |
| 2018 Q1 | 4.99 Million USD | 6.35% |
| 2017 Q3 | 5.53 Million USD | 30.18% |
| 2017 FY | 18.88 Million USD | -31.4% |
| 2017 Q2 | 4.25 Million USD | -3.41% |
| 2017 Q1 | 4.4 Million USD | 84.8% |
| 2017 Q4 | 4.69 Million USD | -15.14% |
| 2016 Q2 | 8.74 Million USD | -24.51% |
| 2016 Q1 | 11.58 Million USD | -16.89% |
| 2016 Q4 | 2.38 Million USD | -50.57% |
| 2016 Q3 | 4.81 Million USD | -44.9% |
| 2016 FY | 27.52 Million USD | -34.1% |
| 2015 Q4 | 13.93 Million USD | 20.97% |
| 2015 FY | 41.77 Million USD | 194.13% |
| 2015 Q1 | 6.99 Million USD | 61.3% |
| 2015 Q2 | 9.31 Million USD | 33.29% |
| 2015 Q3 | 11.52 Million USD | 23.63% |
| 2014 Q3 | 4.11 Million USD | 13.46% |
| 2014 Q4 | 4.33 Million USD | 5.24% |
| 2014 Q2 | 3.63 Million USD | 71.43% |
| 2014 Q1 | 2.11 Million USD | 4.11% |
| 2014 FY | 14.2 Million USD | 60.75% |
| 2013 Q3 | 2.11 Million USD | -5.69% |
| 2013 FY | 8.83 Million USD | 12.04% |
| 2013 Q4 | 2.03 Million USD | -3.76% |
| 2013 Q2 | 2.24 Million USD | -7.96% |
| 2013 Q1 | 2.43 Million USD | 33.32% |
| 2012 Q2 | 1.45 Million USD | -56.77% |
| 2012 Q4 | 1.82 Million USD | 58.59% |
| 2012 Q3 | 1.15 Million USD | -20.74% |
| 2012 Q1 | 3.36 Million USD | -35.95% |
| 2012 FY | 7.88 Million USD | -50.38% |
| 2011 Q1 | 2.19 Million USD | 92.46% |
| 2011 FY | 15.88 Million USD | 326.89% |
| 2011 Q4 | 5.24 Million USD | -10.79% |
| 2011 Q3 | 5.88 Million USD | 102.54% |
| 2011 Q2 | 2.9 Million USD | 32.52% |
| 2010 FY | 3.72 Million USD | 401.74% |
| 2010 Q2 | 962.04 Thousand USD | 83.12% |
| 2010 Q3 | 1.08 Million USD | 12.44% |
| 2010 Q4 | 1.13 Million USD | 5.24% |
| 2010 Q1 | 525.36 Thousand USD | 12.89% |
| 2009 Q1 | 155.58 Thousand USD | 418.73% |
| 2009 FY | 741.82 Thousand USD | -65.55% |
| 2009 Q4 | 465.37 Thousand USD | 22456.73% |
| 2009 Q3 | -2081.58 USD | -102.39% |
| 2009 Q2 | 87.22 Thousand USD | -43.94% |
| 2008 Q4 | 29.99 Thousand USD | -96.5% |
| 2008 Q2 | 156.67 Thousand USD | 0.0% |
| 2008 Q1 | - USD | -100.0% |
| 2008 FY | 2.15 Million USD | 610.51% |
| 2008 Q3 | 857 Thousand USD | 446.99% |
| 2007 Q3 | 9800.56 USD | 0.0% |
| 2007 Q4 | 237.99 Thousand USD | 2328.35% |
| 2007 FY | 303.09 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|